Amosulalol hydrochloride long acting formulation
US4724148A · kind A · utility
22Cited by
11References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 1986 |
| Grant date | Feb 9, 1988 |
| Priority date | — |
| Expiry date | Nov 14, 2006 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Long acting formulations of amosulalol hydrochloride are provided, wherein the frequency of administering the hypotensive agent is minimized and wherein such formulations are prepared by compounding amosulalol hydrochloride with an enterosoluble material and optionally the inclusion of an organic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.